Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephane Zuily

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Lupus|December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.
Arthritis Care & Research|July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of DefinitionsMedha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
Arthritis Care & Research|August 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision AnalysisMedha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
The Journal of Experimental Medicine|September 21, 2021
Implication of folate deficiency in CYP2U1 loss of functionClaire Pujol, Anne Legrand, Livia Parodi, et al.
Annals of Internal Medicine|December 23, 2024
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis, Claire L Vale, Peter J Godolphin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Lupus|December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.
Arthritis Care & Research|July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of DefinitionsMedha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
Arthritis Care & Research|August 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision AnalysisMedha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
The Journal of Experimental Medicine|September 21, 2021
Implication of folate deficiency in CYP2U1 loss of functionClaire Pujol, Anne Legrand, Livia Parodi, et al.
Annals of Internal Medicine|December 23, 2024
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis, Claire L Vale, Peter J Godolphin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Pageof 4